ArticleOncotarget2017

Bevacizumab significantly increases the risks of hypertension and proteinuria in cancer patients: A systematic review and comprehensive meta-analysis.

Tingting Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.